Last reviewed · How we verify
hyaluronic acid-carboxymethylcellulose
hyaluronic acid-carboxymethylcellulose is a Small molecule drug developed by Bucheon St. Mary's Hospital. It is currently FDA-approved.
At a glance
| Generic name | hyaluronic acid-carboxymethylcellulose |
|---|---|
| Sponsor | Bucheon St. Mary's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Ionized Atelocollagen Adhesion Barrier (Collabarrier®) in Spine Surgery (NA)
- Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds (PHASE2)
- Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye (NA)
- Efficacy of Quantum Molecular Resonance Combined With Intense Pulsed Light in Mixed Dry Eye (NA)
- Seprafilm® Adhesion Barrier and Cesarean Delivery (PHASE4)
- The Assessment of the Use of Anti-Adhesion Agents to Prevent Pelvic Postoperative Adhesions (NA)
- Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease (PHASE4)
- Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- hyaluronic acid-carboxymethylcellulose CI brief — competitive landscape report
- hyaluronic acid-carboxymethylcellulose updates RSS · CI watch RSS
- Bucheon St. Mary's Hospital portfolio CI
Frequently asked questions about hyaluronic acid-carboxymethylcellulose
What is hyaluronic acid-carboxymethylcellulose?
hyaluronic acid-carboxymethylcellulose is a Small molecule drug developed by Bucheon St. Mary's Hospital.
Who makes hyaluronic acid-carboxymethylcellulose?
hyaluronic acid-carboxymethylcellulose is developed and marketed by Bucheon St. Mary's Hospital (see full Bucheon St. Mary's Hospital pipeline at /company/bucheon-st-mary-s-hospital).
What development phase is hyaluronic acid-carboxymethylcellulose in?
hyaluronic acid-carboxymethylcellulose is FDA-approved (marketed).